Rehabilitation trial using robotic wear curara(R) for patients with cerebrovascular and neurodegenerative diseases. part 1 cerebrovascular disease
- Conditions
- cerebrovascular disease (CVD)
- Registration Number
- JPRN-UMIN000034237
- Lead Sponsor
- Shinshu University
- Brief Summary
We analyzed data from 35 patients in total (Group A: 17; Group B: 18). The averaged improvement rate of 10 m walking time was 0.21 for Group A, and 0.14 for Group B, respectively (p = 0.099). The averaged improvement rate of 6 min walking distance was 0.17 for Group A, and 0.19 for Group B, respectively (p = 0.677). Group A tended to show better results in several gait parameters taken by RehaGait than Group B, but the difference was not statistically significant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
1) Possible causes for gait disturbance other than CVD 2) Not fulfil the body-size criteria for curara(R) model 4 3) Researchers judge the participants inappropriate for the study (for example, severe dementia or psychiatric symptoms, severe spasticity or joint contracture of paralyzed leg, etc.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 10m walking speed (comparison between day 0 and day 14) [day 0, day 7, day 14] [] indicates day of evaluation
- Secondary Outcome Measures
Name Time Method 1) 6-min walking distance (comparison between day 0 and day 14) 2) RehaGait(R) measures 3) Berg Balance Scale (BBS) [day 0, day 14] 4) Timed up and go test 5) Outcome measures reported by participants [day 14] 6) Safety sheet (interview to participants) [at least 1 day during 3 days just prior to day 0 and day 0-day 14] Items not specified above by [] are evaluated three times, day 0, day 7, and day 14.